Aslan Fred

Aslan Fred is listed in filings as Chief Executive Officer at Artiva Biotherapeutics, Inc.. This profile follows SEC Form 4 activity through May 19, 2026, including sale activity. Recent filings connect the profile to Artiva Biotherapeutics, Inc. (ARTV). The current snapshot covers public activity from Jul 22, 2024 to May 19, 2026. Reported amounts are shown as $244.3K to $19.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.